Products

Accuro 3S
Rivanna Medical
Radiology & Imaging AI
Accuro 3S by Rivanna Medical is an FDA-cleared, AI-enabled diagnostic ultrasound system for real-time neuraxial anesthesia guidance and spinal interventions, featuring continuous in-plane needle tracking and automated anatomical landmark identification.

See all 1 product →

About Rivanna Medical

Rivanna Medical is a medical technology company that develops and commercializes AI-powered clinical decision-support solutions, primarily utilizing proprietary ultrasound imaging hardware and advanced software. Their platform automates complex anatomical analysis at the point of care, aiming to enhance precision, safety, and patient outcomes while reducing variability and expanding access to advanced capabilities. The company’s core technology includes 2D/3D ultrasound-based bone and soft tissue imaging, complemented by AI-driven anatomical guidance and diagnostics, such as BoneEnhance® for superior bone visualization and SpineNav3D™ for automated spinal midline and epidural space identification.

For physicians, Rivanna Medical’s solutions are designed to improve the accuracy and efficiency of needle placements, particularly in procedures like neuraxial anesthesia (epidurals and spinal anesthesia), even in challenging cases involving patients with higher BMI or complex anatomy. Beyond regional anesthesia, their technology extends to comprehensive imaging solutions for fracture detection and musculoskeletal diagnostics, including applications for military medicine to address spinal interventions in austere environments. The company’s FDA-cleared devices and next-generation AI software are developed with a focus on simplifying complex procedures, improving clinical decision-making, and streamlining workflows, ultimately contributing to elevated global standards of care.

Focus Areas

Regional anesthesia Fracture care Spinal needle interventions Musculoskeletal diagnostics AI-driven anatomical guidance Neuraxial anesthesia Pain management Point-of-care ultrasound

Business Intelligence

Key InvestorsBiomedical Advanced Research and Development Authority (BARDA), National Institutes of Health (NIH), Virginia Catalyst Program, Congressionally Directed Medical Research Program (CDMRP), Wallace H. Coulter Foundation
PartnershipsTri-anim Health Services, BOMImed, University of Virginia (UVA), Virginia Commonwealth University (VCU), The Geneva Foundation
TechnologyProprietary clinical datasets, AI models, Purpose-built imaging hardware, Advanced 2D/3D ultrasound-based bone and soft tissue imaging, AI-driven anatomical guidance and diagnostics (BoneVision™ Multi-Probe Multi-Angle Image Acquisition, BoneEnhance® Multi-Frequency Image Reconstruction, SpineNav3D™ AI-Enabled Spine Recognition, SpineNav-AI™ image processing software), Dual-Array™ convex probe, Handheld battery-powered ultrasound hardware, On-device automated depth estimation
FDA Clearances3+ cleared products (estimated)

What Physicians Need to Know

Neuraxial Anesthesia & Spinal Interventions
Rivanna Medical specializes in enhancing the safety, speed, and efficiency of neuraxial anesthesia procedures, including epidurals and spinal blocks. Their Accurou00ae and Accurou00ae 3S systems provide real-time, image-guided needle placement.
AI-Driven Anatomical Guidance
A core specialization is AI-enabled anatomical guidance, utilizing SpineNav-AIu2122 and SpineNav3Du2122 software. This technology automates the identification of spinal midline, interlaminar space, epidural space, and depth, improving precision and reducing user dependence.
Point-of-Care Ultrasound (POCUS)
Rivanna's devices, such as the Accurou00ae 3S, are portable, point-of-care ultrasound systems designed for ease of use in various clinical settings.
Musculoskeletal Diagnostics & Fracture Care
Beyond spinal interventions, Rivanna is developing comprehensive imaging solutions for musculoskeletal diagnostics and fracture detection, aiming to provide radiation-free alternatives to traditional imaging methods.
Pain Management
The company's innovations in neuraxial anesthesia directly contribute to improved pain management by increasing the success and safety of interventional pain procedures.
Physician Tip

Rivanna Medical's technology, particularly the Accurou00ae and Accurou00ae 3S systems, offers significant advantages for physicians. The AI-driven guidance and enhanced imaging capabilities lead to clinically proven increases in first-attempt success rates for spinal procedures, even in complex patient anatomies. This translates to fewer needle passes, reduced procedure times, and improved patient satisfaction with pain control. The handheld, one-handed design, coupled with features like the Dual-Arrayu2122 probe and Needle Guide Kit with stabilization bands, streamlines workflow and enables single-operator efficiency, addressing the 'three-hands' problem. Furthermore, the radiation-free nature of their ultrasound technology provides a safer alternative to fluoroscopy for both patients and clinicians, and it serves as an excellent tool for resident training by visually reinforcing anatomical understanding. The automated anatomical interpretation reduces variability and supports more confident clinical decisions at the point of care.

Rivanna Medical's Accurou00ae 3S platform supports standard B-mode imaging and is equipped with healthcare IT connectivity to implement DICOM-based patient and image archival workflows, facilitating seamless integration into existing hospital and clinical settings.

Products by Rivanna Medical

1 product in the directory

Accuro 3S
Rivanna Medical
Radiology & Imaging AI
Accuro 3S by Rivanna Medical is an FDA-cleared, AI-enabled diagnostic ultrasound system for real-time neuraxial anesthesia guidance and spinal interventions, featuring continuous in-plane needle tracking and automated anatomical landmark identification.

What the Web Says

Rivanna Medical is a medical technology company that develops and commercializes imaging-based medical technologies, with a flagship product called Accuro, a handheld ultrasound device designed to guide neuraxial anesthesia and perform diagnostic imaging. Product reviews for Accuro are generally positive, highlighting its effectiveness in improving first-attempt success rates for spinal and epidural procedures, reducing complications, and enhancing patient care and training. Employer reviews indicate a generally positive work environment with motivated employees and a good work-life balance, though some mention management issues and an unstructured, startup-like atmosphere.

Overall: Positive

Strengths

  • Accuro improves first-attempt success rates in spinal and epidural procedures.
  • Accuro reduces complications like 'spinal headaches' and patient discomfort.
  • Accuro is a valuable tool for training residents in neuraxial anesthesia.
  • The company fosters a productive and fun workplace with motivated employees.
  • Employees experience a good work-life balance.
  • The company encourages creativity and accepts ideas from all employees, even interns.

Limitations

  • Some employees have noted management issues.
  • The company can operate like a 'giant lab instead of a business'.
  • Employees may be required to perform multiple tasks outside their job description.
  • The unstructured environment can sometimes lead to unclear instructions and communication.
  • The job can change regularly, which might be stressful for some.

Based on reviews from: Indeed.com, Rivanna Medical (Testimonials), Handshake, SPARK Product Development, 24x7 Magazine

Last updated: 2026-07-21

Videos

News, demos, and interviews about Rivanna Medical.

Loading videos...

Videos load interactively. If none appear, search YouTube for Rivanna Medical →

View all on YouTube

Press & Coverage

Rivanna Medical
RIVANNA Receives FDA 510(k) Clearance for Accuro XV Musculoskeletal Ultrasound Imaging System
RIVANNA announced FDA 510(k) clearance for its Accuro XV Diagnostic Ultrasound System, enabling commercial use for musculoskeletal imaging in hospitals and clinics. This clearance is a key regulatory milestone as the company expands its AI-enabled imaging platform.
2026-05
Medical Device Network
FDA greenlights Rivanna's AI musculoskeletal imaging system
Rivanna's Accuro XV, an AI-based musculoskeletal imaging system, has received US FDA clearance, paving the way for its commercialization in hospitals and medical clinics across the US. The system uses ultrasound-based bone and 3D soft-tissue imaging with AI software for automated fracture detection.
2026-05
Rivanna Medical
RIVANNA expands multi-site clinical study for Accuro XV musculoskeletal imaging system
RIVANNA has expanded its multi-site clinical study for the Accuro XV musculoskeletal imaging system, accelerating the development of AI-enabled fracture detection and compressing the anticipated FDA 510(k) timeline.
2026-04
Rivanna Medical
RIVANNA's Accuro XV Demonstrates Feasibility of Musculoskeletal Imaging by Non-physician Users With Minimal Training
A study published by RIVANNA demonstrated that its Accuro XV musculoskeletal imaging system can produce diagnostic images of extremity injuries when operated by non-physicians after brief training. This suggests the system's potential to democratize access to high-quality musculoskeletal imaging.
2026-04
Rivanna Medical
RIVANNA nominated for MedTech Scale-Up of the Year at MedTech World Awards 2026 | North America
RIVANNA has been nominated for MedTech Scale-Up of the Year at the MedTech World Awards 2026 | North America, recognizing the company's commercial momentum in AI-powered clinical decision support.
2026-05
Rivanna Medical
RIVANNA announces FDA clearance of Accuro 3S Needle Guide Kit
RIVANNA received FDA 510(k) clearance for its Accuro 3S Needle Guide Kit consumables, a significant milestone for advancing the safety and effectiveness of ultrasound-guided needle placement. The kit is designed for use with the Accuro 3S ultrasound imaging system.
2025-12
PR Newswire
RIVANNA awarded $3 million CDMRP grant to develop military-optimized ultrasound guidance system for spinal interventions
RIVANNA was awarded a $3 million Peer-Reviewed Medical Research Program (PRMRP) Technology/Therapeutic Development Award (TTDA) from the Congressionally Directed Medical Research Program (CDMRP) to develop a military-optimized ultrasound guidance system for spinal interventions.
2025-10
Rivanna Medical
BARDA awards nearly $10 million to RIVANNA to accelerate development of CADe/x AI module for Accuro XV
RIVANNA received $9.92 million in federal funding from BARDA to accelerate the development of an advanced AI module, CADe/x, designed to automate the detection of anatomical abnormalities and assist in the diagnosis of bone fractures for the Accuro XV system.
2025-07

Frequently Asked Questions

Rivanna Medical's flagship product line is Accuro, including Accuro, Accuro Second Generation, and Accuro 3S, which are portable, AI-enabled ultrasound systems. These devices are primarily used for neuraxial anesthesia procedures, such as epidurals and spinal anesthesia, by providing real-time anatomical guidance and automated identification of spinal landmarks and depth measurements. They are designed to improve first-attempt success rates and reduce complications in these interventions, which also supports pain management applications.
Rivanna Medical's Accuro systems integrate AI-enabled technologies like SpineNav3Du2122 and SpineNav-AIu2122 to provide automated anatomical recognition and real-time guidance during POCUS procedures. This AI assists clinicians by automatically identifying crucial spinal structures, measuring depth to the epidural space, and providing a real-time assessment of the scan plane orientation, making spinal needle interventions more efficient and precise, even for less experienced users.
Rivanna Medical is developing the Accuro XV musculoskeletal imaging system, which utilizes ultrasound-based bone and 3D soft-tissue imaging technology with AI-enabled software for automated detection and volumetric assessment of skeletal fractures and soft tissue injuries. This system is intended for use in emergency departments to facilitate timely triage and treatment, offering a radiation-free alternative to X-ray imaging for comprehensive musculoskeletal diagnostics.
Rivanna Medical operates an FDA-registered and ISO 13485:2016 certified manufacturing facility, ensuring their products meet stringent quality management standards. Their Accuro 3S diagnostic ultrasound system and SpineNav-AIu2122 image processing software have received 510(k) clearance from the U.S. Food and Drug Administration (FDA), authorizing their use for anatomical guidance in needle or catheter placement in clinical settings.
Rivanna Medical offers the Accuro Pledge+ Service Plan, which provides comprehensive coverage for their devices. This plan includes full coverage for telephone, technical, and application support, immediate device replacement regardless of damage cause, and all software upgrades for the same product code and model at no additional charge.
The pricing for Rivanna Medical's Accuro systems starts at $5,999 USD, with no cloud subscription required. This initial price point provides access to their ultrasound-enabled neuraxial guidance technology.
Rivanna Medical demonstrates strong company stability, founded in 2010 and operating an FDA-registered, ISO 13485:2016-certified manufacturing facility. They have established strategic partnerships, including a distribution alliance with Tri-anim Health Services for the Accuro product line in the U.S., and significant federal grants and contracts from entities like BARDA for developing Accuro XV and the CDMRP for military-optimized systems.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.